Merit Financial Group LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 40,177 shares of the company's stock, valued at approximately $1,280,000.
A number of other institutional investors have also recently bought and sold shares of the stock. Durable Capital Partners LP lifted its stake in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock valued at $267,557,000 after buying an additional 4,720,988 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Option Care Health by 17.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company's stock valued at $111,076,000 after buying an additional 590,913 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Option Care Health by 6.6% in the third quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company's stock valued at $105,384,000 after buying an additional 235,413 shares in the last quarter. Swedbank AB bought a new position in Option Care Health in the third quarter valued at approximately $49,455,000. Finally, The Manufacturers Life Insurance Company lifted its stake in Option Care Health by 3.3% in the second quarter. The Manufacturers Life Insurance Company now owns 1,706,671 shares of the company's stock valued at $55,433,000 after buying an additional 55,182 shares in the last quarter. Institutional investors own 98.05% of the company's stock.
Analyst Ratings Changes
A number of brokerages have weighed in on OPCH. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley boosted their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 13th. Jefferies Financial Group reissued a "buy" rating and issued a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 13th. TD Cowen reissued a "hold" rating on shares of Option Care Health in a research report on Tuesday, January 27th. Finally, Barrington Research boosted their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the stock an "outperform" rating in a research report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $37.27.
Read Our Latest Report on Option Care Health
Option Care Health Stock Performance
NASDAQ OPCH opened at $28.54 on Friday. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 0.87. The firm's fifty day moving average price is $30.07 and its two-hundred day moving average price is $30.72. Option Care Health, Inc. has a 1 year low of $24.24 and a 1 year high of $36.80. The firm has a market capitalization of $4.48 billion, a P/E ratio of 22.30, a price-to-earnings-growth ratio of 1.59 and a beta of 0.95.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. During the same period in the prior year, the firm posted $0.44 earnings per share. The company's quarterly revenue was up 8.8% compared to the same quarter last year. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.69 EPS for the current year.
Option Care Health Profile
(
Free Report)
Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.